⌘K
Loading ticker…
GRI Bio, Inc. Common Stock · Healthcare · Pharmaceutical Products
As of 2026-06-26, GRI Bio, Inc. Common Stock (GRI) has a 3-month relative strength percentile of 16 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 29. The current market Stance is 47 (Neutral). Sector: Healthcare. Average daily range 8.2%, relative volume 0.93×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
16 is not yet a leadership-grade RS read, Market Stance is 47
YoY sales growth, last 8 quarters. Sales must back the earnings story.
Operating margin unavailable
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Daily range, ATR, beta, and the math for a 1-ADR stop.
GRI is in a stage 4 downtrend, week 2. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -17.1% / -90.7%.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
News
Related searches
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | GRI Jan avg: -38.80% median: -39.88% win: 0% σ: 14.59% n: 3 2023-04-25 → 2026-05-29 | GRI Feb avg: -32.88% median: -26.28% win: 0% σ: 15.50% n: 3 2023-04-25 → 2026-05-29 | GRI Mar avg: -24.95% median: -10.20% win: 0% σ: 30.11% n: 3 2023-04-25 → 2026-05-29 | GRI Apr avg: -27.65% median: -31.09% win: 0% σ: 19.06% n: 4 2023-04-25 → 2026-05-29 | GRI May avg: -18.72% median: -19.93% win: 0% σ: 11.01% n: 4 2023-04-25 → 2026-05-29 | GRI Jun avg: -28.14% median: -28.87% win: 0% σ: 23.33% n: 3 2023-04-25 → 2026-05-29 (current) | GRI Jul avg: -25.49% median: -15.55% win: 0% σ: 30.90% n: 3 2023-04-25 → 2026-05-29 | GRI Aug avg: -29.90% median: -33.68% win: 33% σ: 36.75% n: 3 2023-04-25 → 2026-05-29 | GRI Sep avg: 13.79% median: 22.05% win: 67% σ: 39.20% n: 3 2023-04-25 → 2026-05-29 | GRI Oct avg: 34.82% median: -17.48% win: 33% σ: 93.89% n: 3 2023-04-25 → 2026-05-29 | GRI Nov avg: -18.14% median: -22.15% win: 33% σ: 33.96% n: 3 2023-04-25 → 2026-05-29 | GRI Dec avg: -34.49% median: -37.00% win: 33% σ: 54.47% n: 3 2023-04-25 → 2026-05-29 |